ELEVANCE HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 537.3 USD | -0.45% |
|
+1.10% | +13.93% |
| 04-26 | HCA beats first-quarter profit estimates on higher patient admissions | RE |
| 04-25 | Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing | MT |
| Sales 2024 * | 172B 13,734B | Sales 2025 * | 182B 14,600B | Capitalization | 125B 9,996B |
|---|---|---|---|---|---|
| Net income 2024 * | 8.04B 644B | Net income 2025 * | 9.06B 725B | EV / Sales 2024 * | 0.83 x |
| Net Debt 2024 * | 17.19B 1,376B | Net Debt 2025 * | 12.73B 1,019B | EV / Sales 2025 * | 0.75 x |
| P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
13.7
x | Employees | 104,900 |
| Yield 2024 * |
1.16% | Yield 2025 * |
1.25% | Free-Float | 99.55% |
More Fundamentals
* Assessed data
More news
Latest transcript on Elevance Health, Inc.
More recommendations
More news
| 1 day | -0.45% | ||
| 1 week | +1.10% | ||
| Current month | +3.61% | ||
| 1 month | +3.33% | ||
| 3 months | +11.05% | ||
| 6 months | +21.70% | ||
| Current year | +13.93% |
1 week
527.05
542.07
1 month
493.64542.07
Current year
449.02542.07
1 year
412.00542.07
3 years
355.43549.52
5 years
171.03549.52
10 years
95.18549.52
| Managers | Title | Age | Since |
|---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 19/11/17 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 05/09/23 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | 02-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 30/09/13 | |
| Director/Board Member | 55 | 31/10/22 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 19/11/17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.22% | 18 M€ | +3.79% | - | |
| 2.36% | 1,026 M€ | +6.95% | - | |
| 2.07% | 8 M€ | +2.44% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 537.3 | -0.45% | 700,726 |
| 25/04/24 | 539.7 | +1.11% | 1,066,975 |
| 24/04/24 | 533.7 | +0.15% | 916,012 |
| 23/04/24 | 532.9 | +0.13% | 811,682 |
| 22/04/24 | 532.2 | +0.15% | 1,525,124 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotes
Elevance Health, Inc. is the American leading of health insurance. The group provides a broad range of medical and specialty products and services (life and disability insurance, medication, dental, vision insurance system and behavioral care insurance system, long-term health care insurance, medical expenses management, etc.).
Elevance Health, Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an independent association providing health insurance system.
At the end of 2023, the group had nearly 47 million medical members.
Sector
Managed Healthcare
Calendar
15/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
537.3
USD
Average target price
599.5
USD
Spread / Average Target
+11.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.93% | 125B | |
| -5.91% | 456B | |
| +18.37% | 101B | |
| -0.28% | 39.69B | |
| -33.18% | 36.86B | |
| -5.28% | 20.05B | |
| -13.82% | 3.08B | |
| -28.58% | 337M |
- Stock Market
- Equities
- ELV Stock
